Penn Medicine is widely known for its exceptional patient outcomes, innovative treatment programs, and advanced clinical research. Read why Penn is your choice for a living liver donor transplant.
Penn Medicine has an established track record of patient survival. It is one of nine centers of excellence that are participants in the National Institute of Health-sponsored Adult-to-Adult Living Donor Liver Transplant consortium (A2ALL) that explores outcomes in living donor transplantation.
As leading experts, Penn transplant surgeons and physicians have published numerous articles about living donor transplantation. They perform groundbreaking research regarding liver regeneration, minimization of immunosuppression medications in recipients and long-term quality of life for donors.
Patients who choose Penn for their transplant surgery have access to exceptional care that includes:
- A multidisciplinary team approach. Our team includes experts in surgery, hepatology, psychiatry, and transplant immunology.
- The highest level of hospitality. The Clyde F. Barker Penn Transplant House, a beautiful guest house, provides accommodations for patients and their families and caregivers.
- Innovative strategies. Penn transplant specialists are directly involved in continuously shaping U.S. transplant policy and continue to develop innovative strategies to improve outcomes for patients.